Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis.

Zakai, Neil A; Walker, Rob F; MacLehose, Richard F; Koh, Insu; Alonso, Alvaro; Lutsey, Pamela L

Zakai, Neil A; Walker, Rob F; MacLehose, Richard F; Koh, Insu; Alonso, Alvaro; Lutsey, Pamela L.

Afiliación

Zakai NA; Department of Medicine Larner College of Medicine at the University of Vermont Burlington Vermont USA.
Walker RF; Department of Pathology and Laboratory Medicine Larner College of Medicine at the University of Vermont Burlington Vermont USA.
MacLehose RF; Division of Epidemiology and Community Health School of Public Health University of Minnesota Minneapolis Minnesota USA.
Koh I; Division of Epidemiology and Community Health School of Public Health University of Minnesota Minneapolis Minnesota USA.
Alonso A; Department of Pathology and Laboratory Medicine Larner College of Medicine at the University of Vermont Burlington Vermont USA.
Lutsey PL; Department of Epidemiology Rollins School of Public Health Emory University Atlanta Georgia USA.

Res Pract Thromb Haemost ; 5(6): e12575, 2021 Aug.

Article en En | MEDLINE | ID: mdl-34430789

Palabras clave

anticoagulants; factor Xa inhibitors; secondary prevention; venous thromboembolism; warfarin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Res Pract Thromb Haemost Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google